関連文献

Urinary Level of Liver-Type Fatty Acid Binding Protein Reflects the Degree of Tubulointerstitial Damage in Polycystic Kidney Disease.

Kidney Blood Press Res. 2018PubMed

Urinary liver-type fatty acid-binding protein levels as a potential risk factor for renal dysfunction in male HIV-infected Japanese patients receiving antiretroviral therapy: a pilot study.

Int J STD AIDS. 2018PubMed

Urinary L-FABP level in children with nephrotic syndrome and tubular dysfunction.

Pediatr Int. 2018PubMed

Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucoselowering-independent manner.

BMJ Open Diabetes Res Care. 2017PubMed

Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography.

QJM. 2018PubMed

Role of bardoxolone methyl, a nuclear factor erythroid 2-related factor 2 activator, in aldosterone- and salt-induced renal injury.

Hypertens Res. 2017PubMed

Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1a receptor expression.

Eur J Pharmacol. 2017PubMed

Urinary liver-type fatty acid-binding protein is associated with subendocardial viability ratio in middle- and older-aged adults.

Clin Exp Hypertens. 2017PubMed

Urine liver fatty acid binding protein and chronic kidney disease progression.

Scand J Clin Lab Invest. 2017PubMed

Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes.

Diabetologia. 2017 PubMed